Cellbxhealth PLC DRC (ANPCY)

Currency in USD
0.0670
-0.0018(-2.62%)
Delayed Data·
Showing Cellbxhealth DRC historical data. For real-time data please try another search
Fair Value
Day's Range
0.06700.0680
52 wk Range
0.06661.3200
Key Statistics
Prev. Close
0.067
Open
0.068
Day's Range
0.067-0.068
52 wk Range
0.0666-1.32
Volume
20.48K
Average Volume (3m)
21.69K
1-Year Change
-95.037%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANPCY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Currently not supported.

Cellbxhealth PLC DRC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Cellbxhealth PLC DRC Earnings Call Summary for H2/2025

  • CelLBxHealth revenue plunged 51.7% to GBP 1.4M in 2025; operating losses widened to GBP 19.2M amid slower commercial conversion.
  • Company slashed headcount 60% to 35 employees, cut monthly cash burn below GBP 0.5M, and consolidated operations to one UK facility.
  • Management targets 50% revenue growth in 2026 to ~GBP 2.1M with 65%+ gross margins; expects positive EBITDA by 2028.
  • Strategic pivot toward pharma partnerships over internal product development; currently in talks with half of top 10 pharma companies.
  • Cash position at GBP 4.3M post-fundraise; company funded through Q2 2027 assuming commercial milestones are met and revenue materializes.
Last Updated: 22/06/2026, 12:24
Read Full Transcript

Earnings

Latest Release
Sep 09, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
796K / --
EPS Revisions
Last 90 days

ANPCY Income Statement

Compare ANPCY to Peers and Sector

Metrics to compare
ANPCY
Peers
Sector
Relationship
P/E Ratio
0.0x−1.8x−0.4x
PEG Ratio
0.000.020.00
Price/Book
0.0x2.0x2.6x
Price / LTM Sales
0.0x2.4x3.0x
Upside (Analyst Target)
0.0%70.4%51.9%
Fair Value Upside
Unlock17.2%9.1%Unlock
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.